Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/15/2021
BeiGene Plunges at Shanghai STAR Debut as Risks Overshadow
12/15/2021
China Biopharma, Tech Stocks Fall on Reports of Expanded U.S. Sanction...
12/15/2021
New Study: China Healthcare under Remaking in Digital Era
12/15/2021
Chinese Telemedicine Stocks Feel the Pain as Tougher Rules Loom (WSJ)
12/15/2021
Barrons: Chinese Biotechs Could End Up on U.S. Blacklists
12/15/2021
PharmaDJ's China NMPA Approval Tracker: May 2021
12/14/2021
Comparing Drug Patent Linkage in China and the US
12/14/2021
Antengene Enters Clinical Collaboration with BMS to Evaluate ATG-017 i...
12/14/2021
Everest Med and Providence Therapeutics Join Hands to Co-develop Vacci...
12/14/2021
Sciwind Bio Acquires Global, Exclusive Rights for Sanofi's GIP Recepto...
12/14/2021
China Issues the Provisions for National Pharmaceutical Reserve (2021 ...
12/14/2021
BeiGene Licenses Ex-China Rights of Anti-LAG-3 Antibody LBL-007 from N...
12/14/2021
Innovent Announces Positive Pivotal Phase 2 Results for Parsaclisib (...
12/13/2021
IQVIA: Chinese Hospital Drug Market Growth Slowed to 2.7% in Q3/2021
12/13/2021
NMPA Withdraws Approvals of 210 Domestic Drug Products
12/13/2021
Lilly and Regor Therapeutics Enter $1.5B Strategic Deal for Novel Meta...
12/13/2021
BioInvent and CASI Announce Chinese CTA Approval for NHL Drug BI-1206
12/13/2021
Universe and Kitanihon Enter Strategic Deal with Plan for Kampo Man...
12/13/2021
Keros Therapeutics Announces Licensing Deal with Hansoh Pharma for R...
12/13/2021
Arbutus Biopharma in Licensing Deal With Qilu Pharma in China
12/13/2021
Fosun's Wangbang Discountinues Development of Sirona'sr SGLT2 Inhibito...
12/13/2021
Chinese Couple Arrested in the U.S. for Scheme to Smuggle mRNA Cancer ...
12/13/2021
Biosion Licenses Worldwide Rights of Anti-TROP-2 mAb BSI04702 to OBI P...
12/13/2021
Clover and Ascentage in Clinical Collaboration to Evaluate SCB-313 in...
12/13/2021
CDE: Annual Report on Clinical Trials for New Drug Registration in Chi...
12/13/2021
China's NRDL Explained: 67 New Drugs, 62% Price Cut, 80% Success Rate ...
12/13/2021
Billionaire's Bet on Pfizer Vaccine for China Fails to Pay Off (Bloomb...
12/13/2021
Nine Observations from A Busy Few Weeks Back at the Heart of the China...
12/10/2021
Recent Executive Moves
12/9/2021
Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA to...
Page:
101
/
719
Total number of articles:
21546
:
[First]
[<<]
[99]
[100]
[101]
[102]
[103]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit